HeartWare Receives Second Patient Allotment Under Continued Access Protocol For Pivotal U.S. Bridge-To-Transplant Clinical Trial

PhoenixHerald.com		Friday 10th February 2012	Volume 2012/0210
			Follow us on

	More Breaking Health News
	India, UN envoys land in Maldives amid political crisis
	China's first trade decline in two years triggers fears
	Gilani asked to appear in court after appeal rejected
	Spanish judge convicted for abuse of power
	Afghanistan criticizes NATO for civilian deaths
	25 Syrians killed in twin blasts in Aleppo city
	Protests in Greece as Eurozone lays down fresh bailout conditions
	UK property market shows signs of upturn
	$25 bn settlement with banks to provide relief to US homeowners


Get Breaking Health News headlines emailed to you daily.

HeartWare Receives Second Patient Allotment Under Continued Access Protocol For Pivotal U.S. Bridge-To-Transplant Clinical Trial
Source: Medical News Today
Saturday 4th September, 2010

HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced ...

Read the full story at Medical News Today

Share this page

Email this story to a friend

Have your say on this story